臺灣博碩士論文加值系統

硫酸鈣（CaSO4）與碳酸鈣（CaCO3）由於良好的生物相容性，並且為人體骨骼內主要成分，兩者都廣泛應用於骨缺陷修補材料。此類填充材料的特點為硫酸鈣植入骨缺陷處會在體內降解並被人體吸收，同時產生鈣離子促進骨頭生長，但是若降解後新生骨骼還未生長成型，易形成缺陷而阻礙骨生長。
於硫酸鈣中添加碳酸鈣，碳酸鈣因降解速率慢，當硫酸鈣被人體降解吸收時，周遭碳酸鈣依然存在，因而形成孔洞促進骨細胞生長。將硫酸鈣與碳酸鈣複合成型，製成之骨替代之材料，可解決單一材料的不足性。本實驗依不同重量百分比混合硫酸鈣與碳酸鈣粉末，並水合硬化製成複合材料。再由SEM顯微分析及XRD繞射分析從結晶結構探討添加碳酸鈣對硫酸鈣的物理性質以及機械強度的影響，並量測其降解率及生物相容性（In Vitro研究）。添加後二水硫酸鈣結晶結構之改變，使材料孔隙度上升、抗彎抗壓強度上升、並影響其降解率以及生物相容性。實驗針對試片分析材料降解步驟，轉換成趨勢圖推導出化學反應動力學公式，從而來瞭解此生醫複合材料之降解反應機制。

Because of their excellent biocompatibility, both Calcium carbonate (CaSO4) and Calcium carbonate (CaCO3) are widely used as the bone defect repair materials. However, the fast rate of CaSO4 degradation might cause defects during the implantation, which will obstruct the growth of the bone. Calcium carbonates are used as hydration accelerator and filler component within composites, which reduce the setting time and promote the mechanical strength of calcium composite paste. In this experiment, an optimal incorporation ratio of CaCO3 into CaSO4 bone filler system was introduced. SEM and XRD were used for the characterization of which the crystal structure, physical properties, and mechanical strength of the composite system has been observed.
In addition, the analysis was synchronized from the derivation of reaction mechanisms and the presented kinetics trending-graphs. The influences of degradation and biocompatibility were illustrated from Porosity, Flexural Strength, and Compressive Strength of the specimens that were resulting of CaSO4 crystal structures within variations of added CaCO3.

摘　要 i
ABSTRACT ii
誌　謝 iii
目　錄 iv
表目錄 vi
圖目錄 vii
第一章　緒論 1
1.1　前言 1
1.2　研究背景 2
1.3　研究動機與目的 3
第二章　理論基礎與文獻回顧 4
2.1　生醫材料簡介 4
2.2　生醫材料與體內組織反應 5
2.3　生醫植入材料分類 6
2.4　生醫陶瓷分類 9
2.4.1　惰性、近惰性生醫陶瓷 9
2.4.2　表面活性生醫陶瓷 10
2.4.3　可吸收性生醫陶瓷 11
2.4.4　複合生醫陶瓷材料 12
2.5　半水硫酸鈣的製造與水合 13
2.6　碳酸鈣（CaCO3） 14
2.7　模擬人工體液 16
2.8　骨組織 17
2.8.1　骨組織細胞 18
2.8.2　骨組織生長機制 20
2.9　MTT細胞活性測定 21
第三章　實驗方法 24
3.1　實驗藥品 24
3.2　實驗儀器 24
3.3　實驗流程 25
3.4　實驗試片製備 25
3.5　試片分析與檢測 26
3.5.1　體密度與孔隙度檢測 26
3.5.2　機械性質檢測 27
3.5.3　掃描電子顯微鏡分析 28
3.5.4　EDS元素分析（Energy Dispersive System） 28
3.5.5　X-ray繞射分析 30
3.6　降解實驗 31
3.7　細胞相容性測試 32
3.7.1　MG-63細胞培養 32
3.7.2　MTT細胞生長活性測定 33
第四章　結果與討論 35
4.1　X-ray繞射分析 35
4.2　SEM顯微分析 41
4.3　材料物理性質 50
4.4　材料機械性質 54
4.5　降解實驗 58
4.5.1　各組試片在相同溫度下的降解率 58
4.5.2　反應動力學 61
4.6　EDS成份分析 66
4.7　MTT細胞生長活性測試 69
第五章　結論 72

[1]Mirtch, A. A., Lemaitre, J., “Bone repair of defects filled with a phosphocalcic hydraulic cement:an in vivo study,” J. Mater. Sci. in medicine, Vol. 4, 1993, pp. 337-344.
[2]Janes F.S., “Bioceramics,” 1999, pp. 37-81.
[3]Price N., Bendall S. P., Frondoza C., Jinnah R. H., David S. H., “Human osteoblat-like cells （MG63） proliferate on a bioactive glass surface,” John Wiley & Sons, Inc., Vol. 37, 1997, pp. 394-400.
[4]Coetzee A. S., “Regeneration of bone in the presence of calcium sulfate,” Arch Otolaryngol Vol. 106, 1980, pp. 405-410.
[5]Mckee J.C., Balley B. J., Texas G.., “Calcium Sulfate as a Mandibular Implant. Osteolaryngology- Head and Neck Surgery,” Vol. 92, 1984, pp. 277-286.
[6]G..Georgiou, and J. C.Knowles, “Glass reinforced hydroxyapatite for hard tissue surgery-Part 1: mechanical properties,” Biomaterilas, Vol. 22, 2001, p.2811-2815.
[7]Gomez-Vega J. M. , Saiz E. , Tomsia A. P. , Marshall G. W. and Marshall S. J. , “Bioactive glass coatings with hydroxyapatite and Bioglass particles on Ti-based implants. 1. Processing,“ Biomaterials, Vol. 21, 2000, pp. 105-111.
[8]Cao W. and Hench L. L. , “Bioactive Materials,“ Ceramics International, Vol. 22, 1996, pp. 493-507.
[9]Pasquier G. et al. , “Injectable percutaneous bone biomaterials: an experimental study in a rabbit model：Journal of materials science,“ materials in medicine, Vol. 7, 1996, pp. 683-690.
[10]Gitelis S. , Haggard W. , Piasecki P. , “Use of a Calcium Sulfate-Based Bone Graft Substitute for Benign Bone Lesions,“ Orthopedics, Vol. 24, No. 2, 2001, pp. 162-166.
[11]Coetzee AS., “Regeneration of bone in the presence of calcium sulfate,” Arch Otolaryngol, Vol. 106, 1980, pp. 405-409.
[12]Yu, H.-D., Zhang, Z.-Y., Win, K.Y., Chan, J., Teoh, S.H., Han, M.-Y., “Bioinspired fabrication of 3D hierarchical porous nanomicrostructures of calcium carbonate for bone regeneration,” Volume 46, Issue 35, 21 September 2010, Pages 6578-6580.
[13]C. Combes, R. Bareille, C. Rey, “Calcium carbonate–calcium phosphate mixed cement compositions for bone reconstruction,” Wiley InterScience, 2006, pp.318-328.
[14]Int Endod J, Vol. 34, 2001; pp. 184-188.
[15]K. H. Rateitschak, H. F., “Wolf Color Atlas of Dental Medicline,” Thieme Medical Publishers, 1995, pp.11-24.
[16]M. S. Block, J. N. Kent and L. S. Guerra, “Implants in density,” W. B. Saunders CoMPany, 1997, pp. 45-62.
[17]J. B. Park, “Biomaterials, An Introduction,” New York:Plenue Press, 1979, pp. 4.
[18]「生物體用的陶瓷人工骨骼及其周邊」，工業技術研究院工業材料研究所編譯資料，No MR058,1983。
[19]J. B. Park, “Biomaterials science and engineering” Plenum Press, New York, 1984.
[20]Park JB., “Biomaterials science and Engineering.” Plenum Press, New York and London 1985.
[21]L. Ponsonnet, K. Reybier, N. Jaffrezia, V. Comte, C. Lagneau, M. Lissac, and C.Martelet, “Relationship between surface properties（roughness, wettability） of Titanium and titanium alloys and cell behaviour,” Materials Science and Engineering, Vol. 23, 2003, pp. 551-560.
[22]O. Zinger, K. Anselme, A. Denzer, P. Habersetzer, M. Wieland, J. Jeanfils, P. Hardouin, and D. Landolt, “Time-independent morphology and adhesion of osteoblastic cells titanium model surfaces featuring scale-resolved topography,” Biomaterials, Vol. 25, 2004, pp. 2695-2711.
[23]F. Luthen, R. Lange, P. Becker, J. Rychly, U. Beck, and J. G. B. Nebe, “The influence of surface roughness of titanium on β1- and β3-integrin adhesion and the organization fibronectin in human osteoblastic cells,” Biomaterials, Vol. 26, 2005, pp. 2423-2440.
[24]Eisenbarth E, Meyle J, Nachtigal W, Breme J., “Influence of the surface structure of titanium materials on the adhesion of fibroblast,” Biomaterials, Vol. 17, 1996, pp. 1399-1403.
[25]Gisep, “A. Research on ceramic bone substitutes: current status,” Injury, Vol. 33, 2002, pp. 88-92.
[26]Fujibayashi S, Kim HM, Neo M, Uchida M, Kokubo T, Nakamura T., “Repair of segmental long bone defect in rabbit femur using bioactivetitanium cylindrical mesh cage,” Biomaterials, Vol. 24, 2003, pp. 3445-3451.
[27]Alam MI, Asahina I, Ohmamiuda K, Takahashi K, Yokota S, Enomoto S., “Evaluation of ceramics composed of different hydroxyapatite to tricalcium phosphate ratios as carriers for rhBMP-2.,” Biomaterials , Vol. 22, 2001, pp. 1643-1651.
[28]Saito N, Takaoka T., “New synthetic biodegradable polymers as BMP carriers for bone tissue engineering,” Biomaterials, Vol. 24, 2003, pp. 2287-2293.
[29]Kikuchi M, Itoh S, Ichinose S, Shinomiya K, Tanaka J., “Self-organization mechanism in a bone-like hydroxyapatite/collagen nanocomposite synthesized in vitro and its biological reaction in vivo,” Biomaterials, Vol. 22, 2001, pp. 1705-1711.
[30]P. Vincenzini, “Ceramics in substitutive and reconstructive surgery”, Elsevier Science Publishers B. V., 1991.
[31]B. D. Katthagen, “Bone regeneration with bone substitutes”, Springer-Verlag, 1987.
[32]M. Jarcho, “Calcium phosphate ceramics as hard tissue”, Clin. Orthop. Rel. Res., Vol.157, 1981, p. 259-279.
[33]S. F. Hulbert, J. C. Bokros, L. L. Hench, J. W. Wilson and G. Heimke, “Ceramics in clinical applications, past, present and future”, Ceramics in Clinical Applications, 1987, pp.3-27.
[34]J.F.Shackelford, ”Bioceramics-An Historical Perspective,” Materials science forum, Vol.293, 1999, pp. 1-4.
[35]J. B. Park, “Biomaterials Science and Engineering,” Plennm Inc., 1990.
[36]L. L. Hench and E.C. Ethridge, “Biomaterial” Academic Press Inc., 1982.
[37]廖俊仁，生醫骨科陶瓷材料之發展與應用，生技醫藥專題。
[38]Charles E. Rawlings III, M.D., Robert H. Wilking, M.D.,Jacob S. Hanker, PH.D., Nichilas G. Georgiade,D.D.S.,M.D.,and John M.Harrelson,M.D.”Evaluation in cat of a new material for cranioplasty: a composite of plaster of Paris and hydroxylapatite,” J Neurosurg69, 1988, pp. 269-275.
[39]S. K. Yen., “Titanium Serum and Urine Levels in Rabbit with a Titanium Implant,” Mater. Chem. Phys., Vol. 63, 2000, pp. 256-262.
[40]F. H. Lin, C. H. Yao, C. W. Huang, H. C. Liu, J. S. Sun and C. Y., “Diverse Mechanisms of Osteoblast Spreading on hydroxyapatite and Titanium,” Wang, Mater. Chem. Phys., Vol. 46, 1996, pp. 36-42.
[41]A. oliva, A. Salerno, B. Locardi, V. Riccio, F. D. Ragione, P. Iardino and V. Zappia, “Modificavion of Titanium by IonImplantation of Calcium.” Biomaterials, Vol. 91, 1998, pp. 1019-1025.
[42]N. Price, S. P. Bendall, C. Frondoza, R. H. Jinnah, and David S. H., “John Wiley & Sons Inc,” Vol.37, 1997, pp. 394-400.
[43]化工資訊與商情月刊第4期（92年10月號）
[44]Tadier, S., Bolay, N.L., Fullana, S.G., Rey, C., Combes, C. , “Control of the injectability of calcium carbonate-calcium phosphate mixed cements for bone reconstruction,” Key Engineering Materials,Volume 396-398, 2009, Pages 225-228.
[45]Kalita, S.J., Bose, S., Hosick, H.L., Martinez,S.A.,Bandyopadhyay,A. ,“Calcium carbonate reinforced natural polymer composite for bone grafts,” Advanced Materials and Processes,Volume 724, 2002, Pages 185-190.
[46]“Calcium carbonate-coated polymer rebuilds bone.” Advanced Materials and Processes, Volume 161, Issue 9, September 2003, Page 26.
[47]Uesugi, K., Ogomi, D., Kaneko, T., Akashi, M. ,“Crystal-morphism control of calcium carbonate deposited on/in agarose gel for bone reconstitution,” Polymer Preprints, Japan, Volume 54, Issue 2, 2005, Pages 4945-4946
[48]Wikesjo, U.M.E., Lim, W.H., Razi, S.S., Sigurdsson, T.J., Lee, M.B., Tatakis, D.N., Hardwick, W.R. “Periodontal repair in dogs: A biosabsorbable calcium carbonate coral implant enhances space provision of alveolar bone regeneration in conjunction with guided tissue regeneration,” Journal of Periodontology, Volume 74, Issue 7, 1 July 2003, Pages 957-964.
[49]Koo K-T, Polimeni G, Qahash M, Kim CK, Wikesjo UME,“Periodontal repair in dogs: guided tissue regeneration enhances bone formation in sites implanted with a coral-derived calcium carbonate biomaterial,” J Clin Periodontol 2005; 32: 104–110.
[50]Fontaine ML, Combes C, Sillam T, Dechambre G, Rey C. New calcium-carbonate-based cements for bone reconstruction. Key Engineering Materials 2005;284–286:105–108.
[51]Combes C, Miao B, Bareille R, Rey C. Preparation, physicalchemical characterisation and cytocompatibility evaluation of calcium carbonate cements. Biomaterials 2006;27:1945–1954.
[52]Fontaine ML, Combes C, Mounic S, Rey C. Composition deciment hydraulique a` base de carbonates de calcium. Patent No. FR2830249, 2001.
[53]Penel, G., Pottier, E.C., Leroy, G. , “Raman investigation of calcium carbonate bone substitutes and related biomaterials.” Bulletin du Groupement international pour la recherche scientifique en stomatologie & odontologie, Volume 45, Issue 2-3, May 2003, Pages 56-59.
[54]劉典謨，生醫玻璃/玻璃陶瓷材料，材料與社會，第75期，82年3月。
[55]Radin S. R., Ducheyne P., 1993, “The Effect of Calcium Phosphate Ceramic Composition and Structure on in Vitro Behavior. Ⅱ. Precipitation” J. Biomed. Mater. Res., Vol. 27, pp.35-45.
[56]Feng H. L., Chun J. L., Ko S. C., Jui S. S., Chun P. L., 2001, “Petal-like apatite formed on the surface of tricalcium phosphate ceramic after soaking in distilled water” Biomaterials, Vol. 22, pp. 2981-2992.
[57]Sung B. C., Miyaji F., Kokubo T., Nakamura T., 1997, “Induction of bioactivity of a non-bioactivite glass-ceramic by a chemical treatment” Biomaterials Vol. 18, pp. 1479-1485.
[58]Clifford A., Rafferty A., Mooney P., Wood D., Samuneva B., Matsuya S., “The influence of calcium to phosphate ratio on the nucleation and crystallization of apatite glass- ceramics,” Materials in medicine Vol. 12, 2001, pp. 461-469.
[59]蔡明慈，不同刺激時間單脈衝電磁場對造骨細胞與骨髓細胞共同培養形成之類蝕骨細胞凋亡的影響，碩士論文，中原大學醫學工程研究所，桃園，2002
[60]楊榮森編譯，骨質疏鬆症-病因，診斷，治療，合記圖書出版社，1997，第65-80頁。
[61]G. A. Rodan, “Control of bone formation and resorption: Biological and clinical perspective,” J Cell Biocnem Suppls, Vol. 30, 1998, pp. 55-61.
[62]J. T. Bettany, N. M. Peet, R. G. Wolowacz, T. M Skerry and P. S. Grabowski, “Tetracyclines induce apoptosis in osteoclast,” Bone , vol. 27, 2000, pp. 75-80.
[63]Pariza, M.W., “Animal studies: Summary, gaps, and future research,” American Journal of Clinical Nutrition, Vol. 66, 1997, pp. 1539S-1540S.
[64]Mosmann T., “Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays”, Journal of Immunological Methods, Vol. 65, 1983, pp. 55-63.
[65]程寶鸞，動物細胞培養技術，中國：華南理工大學出版社，1999，第131頁
[66]Liu Y., “Understanding the biological activity of amyloid proteins in vitro: form inhibited cellular MTT reduction to altered cholesterol homeostatis”, Progress in Neuro-Psyvhopharmacology and biological psychiatry, Vol. 23, 1999, pp. 377-395.
[67]Dressmann H:Ueber Knochenplombierung.Beitr KLin Chir 9, 1892, pp. 804-810.
[68]Wang, J.-L., The Assay of Bone Reaction after Implantation of Calcium Sulfate and A Composite of Calcium Sulfate and Calcium Phosphate, Institute of Biomedical Engineering, Journal of Medical and Biological Engineering, Vol. 23, 2003, pp. 205-212.
[69]Yasuharu Yamazaki, Shinichiro Oida, Yasushi Akimoto and Shigetoshi Shioda, “Response of the mouse femoral muscle to an implant of a composite of bone morphogenetic protein and plaster of Paris,” Clinical Orthopaedics and related research, Vol,234, 1988, 240-249.
[70]Peltier L:The use of plaster of Paris to fill large defects in bone. Am J Surg vol. 97, 1959, pp. 311-315.
[71]Peltier LF, Lillo R, “The substitution pf plaster of Paris rods for portions of the diaphysis of the radius in dogs,” Surg Forum, Vol. 6, 1956, pp. 556-558.
[72]Peltier LF., “The uses of Plaster of Paris to fill defects in bone,” Clin Ortho, Vol. 21, 1961, pp. 1-29.
[73]Peltier LF, Orn D., “The effect of the addition of Plaster of Paris to autogenous and homogeneous bone grafts in dogs,” Surg Forum, Vol. 8, 1958, pp. 571-574.
[74]Bell WH, “Resorption characteristics of bone and plaster,” Oral Surg, Vol. 39, 1960, pp. 727.
[75]Shaffer C, App G., “The use of plaster of Paris in treating infrabony periodontal defects in humans,” J Periodontol, Vol. 42, 1971, pp. 685-690.
[76]Khalid A.Ruhaimi, “Effect of adding Resorbable calcium sulfate to grafting materials on early bone regeneration in osseous defects in rabbits,” The International Journal of Oral &Maxillofacial implants, Vol. 15 ,2000 , pp. 859-864.
[77]W. C. Say, “Hot corrosion of a-SiC ceramics by V2O6 melt,” Jourual of materials science 25, 1990, pp. 1614-1617.
[78]Pumb JA. Milroy R. Kaye SB. “Effects of the pH dependence of 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium Bromide-formazan absorption on chemosentivity determined by a novel tetrazolium-based assay,” Cancer Research, Vol. 49, 1989, pp. 4435-40.
[79]王焯林，”骨組織對硫酸鈣及硫酸鈣加磷酸鈣之吸收性和骨再生性比較分析研究”，碩士論文，國立成功大學醫學工程研究所，台南，2001
[80]葉晉志，”鈦添加在磷酸鈣玻璃之生物相容性研究”，碩士論文，國立臺北科技大學材料及資源工程系，台北，2002
[81]許嘉麟，”硫酸鈣之動力學硬化機制研究”，碩士論文，國立臺北科技大學材料及資源工程系，台北，2005
[82]Costantino PD, Friedman CD., “Synthetic bone graft substitutes,” Otolaryng Clin N Am, Vol. 27, 1994, pp. 1037–1074.
[83]Pecora G, De Leonardis D, Ibrahim N, Bovi M, Cornelini R., “The use of calcium sulphate in the surgical treatment of a ‘through and trough’ peroradicular lesion,”
[84]Sungjin Kim, Chan Beum Park, “Mussel-inspired transformation of CaCO3 to bone minerals,” Biomaterials, Volume 31, Issue 25, September 2010, Pages 6628-6634